Asset libraries
Naicons’ asset libraries are some of the largest and most diversified in the world. These collections drive the discovery of new drugs that address unmet medical needs and have broad applicability across a diverse number of therapeutic areas. Read on to learn more about our asset libraries and how they can open the way to new and innovative collaborations.
Microbial strain library
A collection of about 45,000 actinomycetes isolated from different sources using proprietary methods. The collection includes strains from over 60 different genera, including strains belonging to unusual and hard-to-isolate genera rarely found in public strain collections. Many strains have associated genomic information. A historical collection of over 10,000 soil samples can provide a virtually endless source of additional strains.
Read More
Microbial extract library
Using proprietary cultivation methods devised to optimize production of bioactive metabolites, Naicons' strains are used to generate a library of dried microbial extracts in ready-to-screen, 96-well microplates. Different extraction procedures are applied to cultures, ensuring compatibility with most screening assays. Pre-fractionated extracts are also produced.
Read More
Metabolite fingerprints
All extracts are used to generate MS-MS and UV-Vis fingerprints, which are then combined through molecular networking to identify structurally-related metabolites within one extract and among different extracts. By comparison with our database of known microbial products, this approach rapidly identifies common known compounds, unusual known compounds, as well as plenty of novel molecules.
Read More
Purified microbial products
Purified microbial products are also available. This collection includes undescribed compounds, molecules first reported by Naicons' team and other rare metabolites.
Read More
